AAAAAA
Results:
1-15
|
Results: 15
Authors:
von Deutsch, DA
Abukhalaf, IK
Aboul-Enein, HY
Wineski, LE
Potter, DE
Citation: Da. Von Deutsch et al., Entiomeric effects of clenbuterol: Is it (-)-R, (+)-S, or both? Response, CHIRALITY, 13(6), 2001, pp. 281-284
Authors:
Ogidigben, MJ
Potter, DE
Citation: Mj. Ogidigben et De. Potter, Central imidazoline (I-1) receptors modulate aqueous hydrodynamics, CURR EYE R, 22(5), 2001, pp. 358-366
Authors:
Russell, KRM
Potter, DE
Citation: Krm. Russell et De. Potter, Biphasic alterations of cAMP levels and inhibition of norepinephrine release in iris-ciliary body by bremazocine, J PHARM EXP, 298(3), 2001, pp. 941-946
Authors:
Moore, TT
Potter, DE
Citation: Tt. Moore et De. Potter, Kappa opioid agonist-induced changes in IOP: Correlation with H-3-NE release and cAMP accumulation, EXP EYE RES, 73(2), 2001, pp. 167-178
Authors:
Ogidigben, MJ
Chu, TC
Potter, DE
Citation: Mj. Ogidigben et al., Naphazoline-induced suppression of aqueous humor pressure and flow: Involvement of central and peripheral alpha(2)/I-1 receptors, EXP EYE RES, 72(3), 2001, pp. 331-339
Authors:
Zhou, L
Thompson, WJ
Potter, DE
Citation: L. Zhou et al., Functional identification of phosphodiesterase activity in human trabecular meshwork cells, J OCUL PH T, 16(4), 2000, pp. 317-322
Authors:
Von Deutsch, DA
Abukhalaf, IK
Wineski, LE
Aboul-Enein, HY
Pits, SA
Parks, BA
Oster, RA
Paulsen, DF
Potter, DE
Citation: Da. Von Deutsch et al., beta-agonist-induced alterations in organ weights and protein content: Comparison of racemic clenbuterol and its enantiomers, CHIRALITY, 12(8), 2000, pp. 637-648
Authors:
Abukhalaf, IK
von Deutsch, DA
Parks, BA
Wineski, L
Paulsen, D
Aboul-Enein, HY
Potter, DE
Citation: Ik. Abukhalaf et al., Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA, BIOMED CHRO, 14(2), 2000, pp. 99-105
Authors:
Chu, E
Chu, TC
Potter, DE
Citation: E. Chu et al., Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: A Dopamine(3) receptor agonist, J PHARM EXP, 293(3), 2000, pp. 710-716
Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist
Authors:
Russell, KRM
Wang, DR
Potter, DE
Citation: Krm. Russell et al., Modulation of ocular hydrodynamics and iris function by bremazocine, a kappa opioid receptor agonist, EXP EYE RES, 70(5), 2000, pp. 675-682
Authors:
Potter, DE
Close, LM
Roddier, F
Roddier, C
Graves, JE
Northcott, M
Citation: De. Potter et al., A high-resolution polarimetry map of the circumbinary disk around UY Aurigae, ASTROPHYS J, 540(1), 2000, pp. 422-428
Authors:
Chu, TC
Han, P
Han, G
Potter, DE
Citation: Tc. Chu et al., Intraocular pressure lowering by S-allylmercaptocysteine in rabbits, J OCUL PH T, 15(1), 1999, pp. 9-17
Authors:
Zhou, L
Thompson, WJ
Potter, DE
Citation: L. Zhou et al., Multiple cyclic nucleotide phosphodiesterases in human trabecular meshworkcells, INV OPHTH V, 40(8), 1999, pp. 1745-1752
Authors:
Chu, E
Chu, TC
Potter, DE
Citation: E. Chu et al., Potential sites of action of TNPA: A dopamine-2 receptor agonist, EXP EYE RES, 69(6), 1999, pp. 611-616
Authors:
Chu, TC
Ogidigben, MJ
Potter, DE
Citation: Tc. Chu et al., 8OH-DPAT-induced ocular hypotension: Sites and mechanisms of action, EXP EYE RES, 69(2), 1999, pp. 227-238
Risultati:
1-15
|